Patient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1

dc.contributor.authorHo, G. F.
dc.contributor.authorSezer, A.
dc.contributor.authorKilickap, S.
dc.contributor.authorGumus, M.
dc.contributor.authorBondarenko, I.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorGogishvili, M.
dc.contributor.authorHe, X.
dc.contributor.authorGullo, G.
dc.contributor.authorRietschel, P.
dc.contributor.authorQuek, R. G.
dc.date.accessioned2023-09-28T13:23:34Z
dc.date.available2023-09-28T13:23:34Z
dc.date.issued2022
dc.identifier.endpageS1753en_US
dc.identifier.issn0923-7534en_US
dc.identifier.startpageS1573en_US
dc.identifier.urihttp://hdl.handle.net/11727/10807
dc.identifier.volume33en_US
dc.identifier.wos000897943700339en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.annonc.2022.10.372en_US
dc.relation.journalANNALS OF ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePatient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: